TargEDys Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 13

Employees

  • Latest Deal Type
  • M&A

TargEDys General Information

Description

Developer of microbe mechanism designed to control the metabolic disease by modulating the appetite through intervention. The company's mechanism of appetite regulation involves bacterial, hormonal mimetic, proteins that are found naturally in the gut microbiome which moderate the appetite of overweight people and restore the appetite of elderly, cachexia, or anorexic people, enabling people to regulate their eating behavior.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Zone d'activités Nativelle - Bat 4bis
  • 1 Chemin de Saulxier
  • 91160 Longjumeau
  • France
+33 01
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Parent Company
Biocodex
Corporate Office
  • Zone d'activités Nativelle - Bat 4bis
  • 1 Chemin de Saulxier
  • 91160 Longjumeau
  • France
+33 01

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TargEDys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 19-May-2023 Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Later Stage VC 12-Jul-2022 Completed Generating Revenue
3. Later Stage VC (Series A) 11-Apr-2017 Completed Generating Revenue
2. Grant 01-Jan-2017 $1.37M $253K Completed Generating Revenue
1. Angel (individual) 24-Jun-2015 $253K $253K Completed Generating Revenue
To view TargEDys’s complete valuation and funding history, request access »

TargEDys Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
P Shares
P Shares
Ordinary 4,524 $10.414674 $52.07 $52.07 1x $52.07 5.88%
To view TargEDys’s complete cap table history, request access »

TargEDys Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of microbe mechanism designed to control the metabolic disease by modulating the appetite through intervention
Drug Discovery
Longjumeau, France
13 As of 2022

Charlottesville, VA
 

Paris, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TargEDys Competitors (16)

One of TargEDys’s 16 competitors is Rivus Pharmaceuticals, a Venture Capital-Backed company based in Charlottesville, VA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Rivus Pharmaceuticals Venture Capital-Backed Charlottesville, VA
Enterome Venture Capital-Backed Paris, France
Vertero Therapeutics Venture Capital-Backed Woburn, MA
Xenikos Venture Capital-Backed Nijmegen, Netherlands
Vaiomer Accelerator/Incubator Backed Toulouse, France
You’re viewing 5 of 16 competitors. Get the full list »

TargEDys Patents

TargEDys Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4176890-A1 Oxytocin-mimetic compositions and uses thereof Inactive 03-Nov-2021
EP-4426325-A1 Oxytocin-mimetic compositions and uses thereof Inactive 03-Nov-2021
US-20250352589-A1 Oxytocin-mimetic compositions and uses thereof Pending 03-Nov-2021
WO-2023078603-A1 Oxytocin-mimetic compositions and uses thereof Inactive 03-Nov-2021
WO-2023079036-A1 Probiotic composition comprising a lactobacillus salivarius strain, a lactobacillus camelliae strain and a bifidobacterium ruminantium strain Inactive 03-Nov-2021 A61K35/747
To view TargEDys’s complete patent history, request access »

TargEDys Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TargEDys Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bpifrance Sovereign Wealth Fund Minority
Empower AI PE-Backed Company Minority
NCI Gestion PE/Buyout Minority
Normandie Incubation Accelerator/Incubator
Onxy Developpement Corporation Minority
You’re viewing 5 of 8 investors. Get the full list »

TargEDys FAQs

  • When was TargEDys founded?

    TargEDys was founded in 2011.

  • Where is TargEDys headquartered?

    TargEDys is headquartered in Longjumeau, France.

  • What is the size of TargEDys?

    TargEDys has 13 total employees.

  • What industry is TargEDys in?

    TargEDys’s primary industry is Drug Discovery.

  • Is TargEDys a private or public company?

    TargEDys is a Private company.

  • What is TargEDys’s current revenue?

    The current revenue for TargEDys is .

  • How much funding has TargEDys raised over time?

    TargEDys has raised $14.7M.

  • Who are TargEDys’s investors?

    Bpifrance, Empower AI, NCI Gestion, Normandie Incubation, and Onxy Developpement are 5 of 8 investors who have invested in TargEDys.

  • Who are TargEDys’s competitors?

    Rivus Pharmaceuticals, Enterome, Vertero Therapeutics, Xenikos, and Vaiomer are some of the 16 competitors of TargEDys.

  • When was TargEDys acquired?

    TargEDys was acquired on 19-May-2023.

  • Who acquired TargEDys?

    TargEDys was acquired by Biocodex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process